Conference
A Randomized Trial Of Rituximab Vs Observation Following Autologous Stem Cell Transplantation (ASCT) For Relapsed Or Refractory CD20-Positive B Cell Lymphoma: Final Results Of NCIC CTG LY.12
Abstract
Abstract
Authors
Crump M; Kuruvilla J; Kouroukis CT; Benger A; Cheung MC; Berinstein NL; Couban S; Seftel MD; Howson-Jan K; Keating A
Volume
122
Publisher
American Society of Hematology
Publication Date
November 15, 2013
DOI
10.1182/blood.v122.21.155.155
Conference proceedings
Blood
Issue
21
ISSN
0006-4971